Persistence of lung structural and functional alterations at one year post‐COVID‐19 is associated with increased serum PD‐L2 levels and altered CD4/CD8 ratio
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Ivette Buendia-Roldan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico. Hauptthemen laut MEDLINE: COVID-19, Lung, SARS-CoV-2, CD4-CD8 Ratio. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Persistent respiratory symptoms and lung abnormalities post‐COVID‐19 are public health problems. This study evaluated biomarkers to stratify high‐risk patients to the development or persistence of post‐COVID‐19 interstitial lung disease.
Methods
One hundred eighteen patients discharged with residual lung abnormalities compatible with interstitial lung disease (COVID‐ILD patients) after a severe COVID‐19 were followed for 1 year (post‐COVID‐ILD patients). Physical examination, pulmonary function tests, and chest high‐resolution computed tomography (HRCT) were performed. Soluble forms (s) of PD‐L1, PD‐L2, TIM‐3, and GAL‐9 were evaluated in serum and cell culture supernatant, as well as T‐cells subsets and the transmembrane expression of PD‐L1 and PD‐L2 on the cell surface.
Results
Eighty percent of the post‐COVID‐ILD patients normalized their lung function at 1‐year follow‐up, 8% presented COVID‐independent ILD, and 12% still showed functional and HRCT alterations. PD‐L2 levels were heterogeneous during acute COVID‐19 (aCOVID); patients who increased (at least 30%) their sPD‐L2 levels at 1 year post‐COVID‐19 and exhibited altered CD4/CD8 ratio showed persistence of chest tomographic and functional alterations. By contrast, patients who decreased sPD‐L2 displayed a complete lung recovery. sPD‐L1, sTIM‐3, and sGAL‐9 increased significantly during aCOVID and decreased in all patients after 1‐year follow‐up.
Conclusion
Increased sPD‐L2 and an altered CD4/CD8 ratio after 12 months of aCOVID are associated with the persistence of lung lesions, suggesting that they may contribute to lung damage post‐COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
ORCID-Profile: Ranferi Ocaña-Guzmán, Gloria Pérez-Rubio, Leslie Chavez-Galan
Zitieren
APA
Buendia-Roldan, I., Martínez-Espinosa, K., Aguirre, M. J., Aguilar-Duran, H., Palma-Lopez, A., Palacios, Y., Ruiz, A., Ramón-Luing, L. A., Ocaña-Guzmán, R., Pérez-Rubio, G., Falfán-Valencia, R., Selman, M., & Chavez-Galan, L. (2024). Persistence of lung structural and functional alterations at one year post‐COVID‐19 is associated with increased serum PD‐L2 levels and altered CD4/CD8 ratio. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1305
Vancouver
Buendia-Roldan I, Martínez-Espinosa K, Aguirre MJ, Aguilar-Duran H, Palma-Lopez A, Palacios Y, et al. Persistence of lung structural and functional alterations at one year post‐COVID‐19 is associated with increased serum PD‐L2 levels and altered CD4/CD8 ratio. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1305
BibTeX
@article{BuendiaRoldan2024,
author = {Buendia-Roldan, Ivette and Martínez-Espinosa, Karen and Aguirre, Maria-Jose and Aguilar-Duran, Hiram and Palma-Lopez, Alexia and Palacios, Yadira and Ruiz, Andy and Ramón-Luing, Lucero A and Ocaña-Guzmán, Ranferi and Pérez-Rubio, Gloria and Falfán-Valencia, Ramcés and Selman, Moisés and Chavez-Galan, Leslie},
title = {Persistence of lung structural and functional alterations at one year post‐COVID‐19 is associated with increased serum PD‐L2 levels and altered CD4/CD8 ratio},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1305}
}
EUVIMED